Infliximab-associated Chiasmopathy

被引：0
|
作者：
Farrell, Erin [1 ]
Sacks, Joel G. [1 ]
机构：
[1] Ochsner Clin Fdn, Dept Ophthalmol, 1514 Jefferson Highway, New Orleans, LA 70121 USA
来源：
OCHSNER JOURNAL | 2008年 / 8卷 / 03期
关键词：
infliximab; optic neuropathy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Optic neuropathy has been reported in association with the use of tumor necrosis factor-alpha antagonists such as etanercept, infliximab, and adalimumab. This is a report of a patient who began experiencing decreased vision approximately 1 month after starting infliximab therapy for rheumatoid arthritis. Visual field testing showed bitemporal hemianopic scotomas, indicating involvement of the nerve fibers in the optic chiasm. The infliximab was discontinued, and the patient experienced substantial improvement in her visual acuity and visual field.
引用
收藏
页码：140 / 145
页数：6
相关论文
共 50 条
  • [31] Infliximab-Associated Psoriasiform Dermatitis: Case Report and Review of a Seemingly Paradoxical Inflammatory Response
    Loh, Tiffany Y.
    Cohen, Philip R.
    CUREUS, 2016, 8 (09):
  • [32] Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin
    Naruse, Hiroya
    Nagashima, Yu
    Maekawa, Risa
    Etoh, Takafumi
    Hida, Ayumi
    Shimizu, Jun
    Kaida, Ken-ichi
    Shiio, Yasushi
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (11) : 1618 - 1619
  • [33] Chiasmopathy?
    Danesh-Meyer, H
    Kubis, KC
    Wolf, MA
    Lessell, S
    SURVEY OF OPHTHALMOLOGY, 2000, 44 (04) : 329 - 335
  • [34] Infliximab-Associated Psoriasis in Children With Crohn's Disease May Require Withdrawal of Anti-Tumor Necrosis Factor Therapy
    Broge, Tangra
    Nam Nguyen
    Sacks, Alan
    Davis, Michael
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (05) : E75 - E77
  • [35] Infliximab-Associated Suppression of Cytokine Release by Mucosal Explants Predicts Success of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
    Otsubo, Takeshi
    Alsahwi, Nassib
    Wahed, Renaisa
    Anand, Rajsavi
    Cheifetz, Adam S.
    Wolf, Jacqueline L.
    Bousvaros, Athos
    Snapper, Scott
    Lamont, J. Thomas
    Robson, Simon
    Moss, Alan C.
    Kokkotou, Efi
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S43 - S44
  • [36] Ethambutol Induced Optic Chiasmopathy
    Mathew, Subin
    Seetharam, Raghavendra
    Kamble, Ravindra
    Battu, Rajani
    ANNALS OF NEUROLOGY, 2012, 72 : S30 - S30
  • [37] Sibling Ethambutol Optic Chiasmopathy
    Jayanetti, Viran
    Rossiter-Thornton, Michael
    Azar, Domit
    Fraser, Clare L.
    NEURO-OPHTHALMOLOGY, 2018, 42 (01) : 40 - 43
  • [38] Infliximab-Associated Chronic Inflammatory Central Nervous System Disease and Peroneal Nerve Injury in a Psoriatic Patient Refractory to Treatment: Case Report with 10-Year Follow-Up
    Signore, Sandra C.
    Brauns, Birka
    Schuetze, Gunther
    Dohm, Christoph P.
    Baehr, Mathias
    Moessner, Rotraut
    Kermer, Pawel
    CASE REPORTS IN NEUROLOGY, 2018, 10 (01) : 12 - 17
  • [39] Tuberculosis associated with infliximab
    Reactions Weekly, 2001, 874 (1) : 3 - 3
  • [40] Mortality associated with infliximab
    Lankarani, KB
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) : 255 - 256
12345